Retrospective Study
Copyright ©The Author(s) 2019.
World J Clin Cases. Sep 26, 2019; 7(18): 2712-2721
Published online Sep 26, 2019. doi: 10.12998/wjcc.v7.i18.2712
Table 2 Univariate and multivariate analyses of prognostic factors for the entire study population
VariableUnivariate analysis
Multivariate analysis
Hazard ratio (95%CI)P-valueHazard ratio (95%CI)P-value
Status of 14v dissection0.9800.900
14vD (-)1 (ref)1 (ref)
14vD (+)1.01 (0.64-1.58)0.97 (0.59-1.60)
Age group0.5690.234
< 65 yr1 (ref)1 (ref)
≥ 65 yr1.15 (0.71-1.86)1.40 (0.80-2.45)
Gender0.781
Male1 (ref)1 (ref)0.721
Female0.94 (0.60-1.46)0.91 (0.56-1.50)
Tumor size0.4550.448
< 4 cm1 (ref)1 (ref)
≥ 4 cm1.19 (0.76-1.86)0.82 (0.50-1.56)
Histologic grade0.2750.162
Differentiated1 (ref)1 (ref)
Undifferentiated1.34 (0.80-2.24)1.51 (0.85-2.71)
pT stage0.0040.033
T11 (ref)1 (ref)
T24.88 (1.13-20.99)4.97 (1.11-22.28)
T38.32 (1.96-35.29)6.58 (1.45-29.92)
T49.17 (2.2-38.21)7.87 (1.84-33.74)
pN stage0.0020.018
N01 (ref)1 (ref)
N12.29 (1.07-4.90)2.08 (0.92-4.67)
N22.18 (1.20-3.97)2.01 (1.06-3.81)
N3a3.11 (1.71-5.63)2.82 (1.49-5.36)
N3b4.30 (1.46-12.65)3.90 (1.22-12.45)
Postoperative chemotherapy0.7990.368
No1 (ref)1 (ref)
Yes1.06 (0.67-1.70)0.78 (0.46-1.33)